Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Poor Americans in the United States suffer hidden burden of parasitic and other neglected diseases

Poor Americans in the United States suffer hidden burden of parasitic and other neglected diseases

December 26, 2007

Large numbers of the poorest Americans living in the United States are suffering from some of the same parasitic infections that affect the poor in Africa, Asia, and Latin America, says the Editor-in-Chief of PLoS Neglected Tropical Diseases.

In an article entitled "Poverty and Neglected Diseases in the 'Other' America," Professor Peter Hotez (George Washington University and the Sabin Vaccine Institute) says that there is evidence that the parasitic diseases toxocariasis, cysticercosis and toxoplasmosis as well as other neglected infections are very common in the United States, especially among poor and underrepresented minority populations living in inner cities and poor rural areas. Such infections are known as neglected tropical diseases (NTDs) because they afflict mostly poor people and are often ignored by public health officials and political leaders despite their enormous medical importance.




Toxocariasis, caused by the roundworm Toxocara canis, is now a common parasitic infection among inner city African-American and Hispanic children. Possibly as many as 23% of Americans living in poverty are exposed to this parasitic worm, in whom it causes a lung disease that resembles asthma, as well as liver and brain disease. Cysticercosis, caused by the tapeworm Taenia solium, is emerging as the leading cause of epilepsy among Hispanic populations in the US, and toxoplasmosis is an important cause of congenital birth defects among Mexican Americans and African Americans.

"Because these parasitic infections only occur among impoverished people and mostly underrepresented minorities in the US," he says, "I believe that there has been a lack of political will to study the problem. It is easier to allow these diseases of poverty to simply remain neglected."

In addition to the neglected diseases above, significant numbers of American schoolchildren living in poor areas may also be infected with other parasites, including Ascaris roundworms in the South, Strongyloides threadworms in Appalachia, Leishmania protozoan parasites in Texas, and the bacteria that cause leptospirosis.

"That reliable numbers on the actual prevalence of these neglected tropical diseases in the United States are simply not available is reflective of their neglected status, and their disproportionate impact on minorities and poor people," says Professor Hotez. "There is an urgent need to support studies that assess the disease burden resulting from these diseases in the United States, identify the minority populations at greatest risk, and identify simple and cost-effective public health solutions."

A related study in this week's journal, by Thomas Nutman (National Institutes of Health, Bethesda, Maryland, USA ) and colleagues, documents a sizeable number of imported cases to the US of parasitic worm infections (filarial infections) that are predominantly found in the developing world.

Dr. Nutman and colleagues examined data from The GeoSentinel Surveillance Network, a global network of medical and travel clinics established in 1995 to detect trends in illnesses among US travelers. Filarial infections, such as river blindness, elephantiasis, and African eyeworm comprised 0.62% (271) of the 43,722 medical conditions reported to the GeoSentinel Network between 1995 and 2004. Immigrants from filarial-endemic regions comprised the group most likely to have acquired a filarial infection; sub-Saharan Africa was the region of the world where the majority of filarial infections were acquired.

Public Library of Science



Related Neglected Disease Current Events and Neglected Disease News Articles
Alarming new data shows TB-HIV co-infection a bigger threat
The World Health Organization released staggering new data about the threat of tuberculosis and the toll it takes on people with HIV/AIDS today, in recognition of World TB Day.

How much is the world spending on neglected disease research and development?
The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total.

COPD â€" a neglected disease (pp 564, 613)
A new series of 5 seminars about one of the largest causes of death and disability worldwide-COPD (chronic obstructive pulmonary disease-starts in this week's issue.    COPD is a major global health problem that has an increasing disease burden and effect on health-care spending. COPD has recently been described by the WHO Global Obstructive Lung Disease (GOLD) initiative as a disease "characterised by airflow limitation that is not fully reversible. The airflow limitation in most cases is both progressive and associated with an abnormal inflammatory response of the lungs to noxious particles or gases". This progressive and relentless loss of lung function is the resu
More Neglected Disease Current Events and Neglected Disease News Articles
Forgotten People, Forgotten Diseases: The Neglected Tropical Diseases and Their Impact on Global Health and Development

Forgotten People, Forgotten Diseases: The Neglected Tropical Diseases and Their Impact on Global Health and Development
by Peter J., Ph.D. Hotez (Author)

Some of the worst tropical diseases in the world have too long been ignored. Parasitic and bacterial diseases such as hookworm, snail fever, river blindness, guinea worm, elephantiasis, sleeping sickness, and leprosy are the most common infections of third-world populations. These neglected tropical diseases (NTDs) represent one of the most important reasons why populations living in Africa, Asia, and Central and South America remain caught in a vicious cycle of poverty, stigma, and despair.

With a lifetime devoted to the subject of tropical diseases, the well-known expert Dr. Peter Hotez provides a comprehensive view of these forgotten diseases. Written in accessible, straightforward language, Forgotten People, Forgotten Diseases thoroughly explains the most significant NTDs,...

Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary

Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies: Workshop Summary
by Theresa Wizeman (Author), Sally Robinson (Author), Robert Giffin (Author), Development, and Translation Forum on Drug Discovery (Author), Institute of Medicine (Author)

The process for developing new drug and biologic products is extraordinarily expensive and time-consuming. Although large pharmaceutical companies may be able to afford the cost of development because they can expect a large return on investment, organizations developing drugs to treat rare and neglected diseases are unable to rely on such returns.

On June 23, 2008, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held a public workshop, "Breakthrough Business Models: Drug Development for Rare and Neglected Diseases and Individualized Therapies," which sought to explore new and innovative strategies for developing drugs for rare and neglected diseases.

Vaccines for Biodefense and Emerging and Neglected Diseases

Vaccines for Biodefense and Emerging and Neglected Diseases
by Alan D.T. Barrett (Author), Lawrence R. Stanberry (Author)

The last 20 years has seen a rapid increase in infectious diseases, particularly those that are termed "emerging diseases" such as SARS, "neglected diseases" such as malaria and those that are deemed biothreats such as anthrax. It is well-recognized that the most effective modality for preventing infectious diseases is vaccination. This book provides researchers with a better understanding of what is currently known about these diseases, including whether there is a vaccine available or under development. It also informs readers of the key issues in development of a vaccine for each disease.



* Provides a comprehensive treatise of the agents that are responsible for emerging and neglected diseases and those that can be used as...

Neglected Diseases: A Human Rights Analysis (Special Topics) (Special Topics in Social  Economic and Behavioural Research Report Series)

Neglected Diseases: A Human Rights Analysis (Special Topics) (Special Topics in Social Economic and Behavioural Research Report Series)
by P. Hunt (Author), J. Mesquita (Author), L. Oldring (Author), R. Stewart (Author)

This report is the result of collaboration between the Special Programme for Research and Training in Tropical Diseases (TDR), the High Commissioner for Human Rigths (HHR) team and the United Nations (UN) Special Rapporteur on the right of everyone to the highest attainable standard of health. Neglected diseases are both a cause and consequence of human rights violations. The failure to respect certain human rights, such as the rights to water, adequate housing, education and participation, increases the vulnerability of individuals and communities to neglected diseases. People afflicted by neglected diseases are vulnerable to violations of their human rights, including the rights to health, life, non-discrimination, privacy, work, education, and to enjoy the benefits of scientific...

Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases

Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases
by Michael Kremer (Author), Rachel Glennerster (Author)

Millions of people in the third world die from diseases that are rare in the first world--diseases like malaria, tuberculosis, and schistosomiasis. AIDS, which is now usually treated in rich countries, still ravages the world's poor. Vaccines offer the best hope for controlling these diseases and could dramatically improve health in poor countries. But developers have little incentive to undertake the costly and risky research needed to develop vaccines. This is partly because the potential consumers are poor, but also because governments drive down prices.

In Strong Medicine, Michael Kremer and Rachel Glennerster offer an innovative yet simple solution to this worldwide problem: "Pull" programs to stimulate research. Here's how such programs would work. Funding agencies would commit...

  Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.(Book review): An article from: Ethics & International Affairs
by Rekha Nath (Author)

This digital document is an article from Ethics & International Affairs, published by Thomson Gale on December 1, 2005. The length of the article is 1460 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases.(Book review)
Author: Rekha Nath
Publication: Ethics & International Affairs (Magazine/Journal)
Date: December 1, 2005
Publisher: Thomson Gale
Volume: 19 Issue: 3 Page: 103(4)

Article Type: Book review

Distributed by Thomson...

  International Perspectives on Neglected Sexually Transmitted Diseases: Impact on Venereology, Infertility, and Maternal and Infant Health
by King K. Holmes (Editor)



  Catastrophes, Epidemics and Neglected Diseases: San Francisco General Hospital and the Evolution of Public Care
by F. William & Grossman, Moses Blaisdell (Author)



  Strong Medicine:Creating Incentives for Pharmaceutical Research on Neglected Diseases
by R.Glennerster M.Kremer (Author)



  Neglected Diseases in East Asia: Are Publilc Health Programs Working?: Hearing Before the Subcommittee on East Asian and Pacific Affairs of the Commit
by Not Avail (Publisher)



© 2009 BrightSurf.com